Levocetirizine Hasco

Levocetirizine, the active ingredient in Levocetirizine Hasco, is a second‑generation H1 antihistamine presented as an oral tablet for oral use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and children.

GNH USA supplies Levocetirizine Hasco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine is a selective H1‑receptor antagonist used to manage allergic disorders. - Allergic rhinitis: relieves nasal congestion, sneezing, itching and watery discharge. - Seasonal allergic rhinitis: reduces symptoms triggered by pollen or other seasonal allergens. - Chronic idiopathic urticaria: diminishes hives and associated itching, improving quality of life.

Levocetirizine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Drowsiness: mild sleepiness, especially at treatment initiation. - Dry mouth: reduced salivation causing throat discomfort. - Headache: transient tension‑type headache. - Nausea: occasional stomach upset. - Taste alteration: metallic or altered taste perception.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or tongue requiring urgent care. - Anaphylactic reaction: severe, systemic allergic response. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: abnormal liver function tests. - Cardiac arrhythmia: rare reports of QT prolongation.

Before using Levocetirizine, consider the following safety measures. - Renal function assessment: dose may need adjustment in severe renal impairment. - Hepatic impairment: use with caution in patients with liver disease. - Sedation monitoring: avoid operating machinery if drowsiness occurs. - Pediatric use: not recommended for children under six years without medical advice. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levocetirizine may interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Other sedating antihistamines: additive drowsiness. - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma levels. - Alcohol: enhances central nervous system depression.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, opioids): monitor for enhanced sedation. - Anticholinergic agents (e.g., diphenhydramine): may increase dry‑mouth risk. - Theophylline: possible alteration of its plasma concentration.